The deal is expected to close in late Q2 2025, subject to Nevro shareholder and regulatory approval.Globus Medical also ...

Globus Medical will acquire Nevro for $250 million in cash, enhancing its musculoskeletal technology portfolio andglobal marketreach. Globus Medical and Nevro Corp. have agreed on an all-cash ...

With the addition of Nevro, Globus said it anticipates in annual net sales this year to total between $2.8 billion and $2.9 billion. Globus Medical’s financial adviser for the deal is Morgan ...

The acquisition, announced today, will see Globus Medical buy all outstanding shares of Nevro for $5.85 each. The transaction price is a 27% premium over Nevro's 90-day volume-weighted average ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add ...

AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NVRO), a global medical device company ...

(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, in an all-cash transaction. Under the terms of the ...

AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp ...

April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical (GMED), Inc. , a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp ...